Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Straub

Showing results (71-80 of 374) with videos related to

Pageof 38
Sort By:
JAMA Neurology|March 12, 2019
Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar DatabaseShuko Joseph, Cunyi Wang, Kate Bushby, et al.
Neuromuscular Disorders : NMD|November 25, 2023
Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseasesCarla Bolano-Diaz, José Verdú-Díaz, Alejandro Gonzalez-Chamorro, et al.
Neurology. Genetics|October 8, 2024
A Titin Truncating Variant Causing a Dominant Myopathy With Cardiac Involvement in a Large Family: The Exception That Proves the RuleKristl G Claeys, Marco Savarese, Per Harald Jonson, et al.
Neurology|August 12, 2016
Cardiac involvement in hereditary myopathy with early respiratory failure: A cohort studyHannah E Steele, Elizabeth Harris, Rita Barresi, et al.
Neuromuscular Disorders : NMD|October 21, 2015
Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
The Journal of Endocrinology|February 22, 2022
Combined growth hormone and insulin-like growth factor-1 rescues growth retardation in glucocorticoid-treated mdxmice but does not prevent osteopeniaClaire L Wood, Rob van 't Hof, Scott Dillon, et al.
Skeletal Muscle|November 29, 2022
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient miceZoe White, Zeren Sun, Elodie Sauge, et al.
Plos Currents|June 22, 2013
Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysisElizabeth Harris, Steve Laval, Judith Hudson, et al.
Neuromuscular Disorders : NMD|May 16, 2026
Sensory neuronopathy secondary to gene therapy with AT845 for Pompe diseaseLaura Pena-Guzman, Carla Bolano-Díaz, Cinta Lleixà, et al.
Human Gene Therapy Methods|October 19, 2012
Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsenKaren Anthony, Lucy Feng, Virginia Arechavala-Gomeza, et al.
Pageof 38

Showing results (71-80 of 374) with videos related to

Sort By:
Pageof 38
JAMA Neurology|March 12, 2019
Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar DatabaseShuko Joseph, Cunyi Wang, Kate Bushby, et al.
Neuromuscular Disorders : NMD|November 25, 2023
Magnetic resonance imaging-based criteria to differentiate dysferlinopathy from other genetic muscle diseasesCarla Bolano-Diaz, José Verdú-Díaz, Alejandro Gonzalez-Chamorro, et al.
Neurology. Genetics|October 8, 2024
A Titin Truncating Variant Causing a Dominant Myopathy With Cardiac Involvement in a Large Family: The Exception That Proves the RuleKristl G Claeys, Marco Savarese, Per Harald Jonson, et al.
Neurology|August 12, 2016
Cardiac involvement in hereditary myopathy with early respiratory failure: A cohort studyHannah E Steele, Elizabeth Harris, Rita Barresi, et al.
Neuromuscular Disorders : NMD|October 21, 2015
Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT)Erik Landfeldt, Anna Mayhew, Michelle Eagle, et al.
The Journal of Endocrinology|February 22, 2022
Combined growth hormone and insulin-like growth factor-1 rescues growth retardation in glucocorticoid-treated mdxmice but does not prevent osteopeniaClaire L Wood, Rob van 't Hof, Scott Dillon, et al.
Skeletal Muscle|November 29, 2022
Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient miceZoe White, Zeren Sun, Elodie Sauge, et al.
Plos Currents|June 22, 2013
Undiagnosed genetic muscle disease in the north of England: an in depth phenotype analysisElizabeth Harris, Steve Laval, Judith Hudson, et al.
Neuromuscular Disorders : NMD|May 16, 2026
Sensory neuronopathy secondary to gene therapy with AT845 for Pompe diseaseLaura Pena-Guzman, Carla Bolano-Díaz, Cinta Lleixà, et al.
Human Gene Therapy Methods|October 19, 2012
Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsenKaren Anthony, Lucy Feng, Virginia Arechavala-Gomeza, et al.
Pageof 38